|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 18, 2012
Palomar Medical Technologies, Inc.
(Exact Name of Registrant as Specified in Charter)
|
|
Delaware
(State or other jurisdic-
tion of incorporation)
|
1-11177
(Commission
File Number)
|
04-3128178
(IRS Employer
Identification Number)
|
|
15 Network Drive, Burlington, Massachusetts 01803
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code (781) 993-2300
|
Item 5.07. Submission of Matters to a Vote of Security Holders.
At the annual meeting of stockholders of Palomar Medical Technologies, Inc. (the “Company”) held on May 16, 2012 (the “2012 Annual Meeting”), the Company’s stockholders voted on the following proposals:
1. The following nominees were elected to the Company’s Board of Directors for terms expiring at the 2013 annual meeting of stockholders.
|
For
|
Withheld
|
Broker Non-Votes
|
|
|
Joseph P. Caruso
|
12,646,244
|
524,993
|
3,920,958
|
|
Jeanne Cohane
|
12,632,083
|
539,154
|
3,920,958
|
|
Damian N. Dell’Anno
|
12,871,076
|
300,161
|
3,920,958
|
|
Nicholas P. Economou
|
10,546,817
|
2,624,420
|
3,920,958
|
|
James G. Martin
|
10,547,519
|
2,623,718
|
3,920,958
|
|
A. Neil Pappalardo
|
10,544,017
|
2,627,220
|
3,920,958
|
|
Louis P. Valente
|
12,644,894
|
526,343
|
3,920,958
|
2. A non-binding, advisory proposal on the compensation of the Company’s named executive officers was disapproved.
|
For:
|
5,761,189
|
|
Against:
|
6,496,922
|
|
Abstain:
|
913,126
|
|
Broker Non-Votes:
|
3,920,958
|
3. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December, 31 2012 was ratified.
|
For:
|
16,850,431
|
|
Against:
|
210,689
|
|
Abstain:
|
31,075
|
4. A shareholder proposal relating to majority voting in Director elections was approved by a majority of the votes cast at the 2012 Annual Meeting.
|
For:
|
10,142,626
|
|
Against:
|
2,945,049
|
|
Abstain:
|
83,562
|
|
Broker Non-Votes:
|
3,920,958
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Palomar Medical Technologies, Inc.
|
|
|
Date: May 18, 2012
|
/s/ Joseph P. Caruso |
| Joseph P. Caruso | |
|
President, Chief Executive Officer, Director, and Chairman of the Board of Directors
|
|